Maplight Therapeutics, Inc.

MPLT

Financials

10-QQ2 ended 06/30/2608/13/2610-QQ1 ended 03/31/2605/14/2610-KFY 202503/26/2610-QQ3 ended 09/30/2512/04/25

Disclosures

8-KCurrent report08/13/268-KCurrent report07/27/268-KCurrent report06/24/268-KCurrent report06/22/268-KCurrent report06/18/26

Prospectuses and Registrations

424B3Prospectus09/23/26S-1/ARegistration statement (amended)09/18/26S-1Registration statement (IPO)09/09/26S-8Registration of securities for employees03/26/26424B3Prospectus10/27/25

Proxies

DEF 14ADefinitive proxy04/29/26DEFA14AAdditional proxy materials04/29/26

Ownership

Form 4Insider transaction10/16/26Form 4Insider transaction10/16/26Form 4Insider transaction10/16/26Form 4Insider transaction10/16/26Form 4Insider transaction10/16/26

Other

EFFECTRequest for effectiveness09/23/26ARSAnnual report to shareholders04/29/268-A12B8-A12B10/24/25CERTCEO/CFO certification10/24/25DRS/ADRS/A08/22/25